Search Results
Phase Ib trial of ianalumab and ibrutinib in CLL
Phase Ib trial of ianalumab plus ibrutinib for CLL
Phase Ib trial of ianalumab plus ibrutinib for CLL
Ianalumab add-on therapy in CLL patients receiving ibrutinib
MRD outcomes from GLOW: venetoclax and ibrutinib in CLL
Dr. Smith on Ibrutinib-Based Therapies in CLL
Epcore CLL-1: Phase I trial of epcoritamab in r/r CLL
Ibrutinib and FCR in CLL irrespective of IGHV mutation status
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL
Exploring Early Ibrutinib Intervention in High-Risk CLL
CAPTIVATE: Ibrutinib and venetoclax in CLL
First-line ibrutinib and venetoclax in CLL
